Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]

Appeal

Appeal letter : Appeal letter (MSWord 186 KB)

Scrutiny letter : Scrutiny letter (MSWord 97 KB)

Response to scrutiny letter : Response to scrutiny letter (MSWord 27 KB)

Final scrutiny letter : Final scrutiny letter (MSWord 81 KB)

Appeal letter : Appeal letter (MSWord 85 KB)

Scrutiny letter : Scrutiny letter (MSWord 100 KB)

Response to scrutiny letter : Response to scrutiny letter (MSWord 77 KB)

Final scrutiny letter : Final scrutiny letter (MSWord 82 KB)

Appeal letter : Appeal letter (MSWord 142 KB)

Scrutiny letter : Scrutiny letter (MSWord 97 KB)

Response to scrutiny letter : Response to scrutiny letter (MSWord 106 KB)

Final scrutiny letter : Final scrutiny letter (MSWord 81 KB)

Appeal letter : Appeal letter (MSWord 134 KB)

Scrutiny letter : Scrutiny letter (MSWord 93 KB)

Response to scrutiny letter : Response to scrutiny letter (MSWord 165 KB)

Final scrutiny letter : Final scrutiny letter (MSWord 89 KB)

Final draft guidance

Final draft guidance (PDF 320 KB)

Equality impact assessment (downloadable version) (PDF 126 KB)

Committee papers (PDF 1.83 MB)

Draft guidance: 2

Draft consultation document (online commenting)

Draft guidance (downloadable version) (PDF 337 KB)

Equality and health inequalities assessment (downloadable version) (PDF 123 KB)

Public committee slides (PDF 787 KB)

Draft guidance: 1

Draft guidance (downloadable version) (PDF 229 KB)

Draft consultation document (online commenting)

Equality impact assessment (downloadable version) (PDF 123 KB)

Committee papers (PDF 4.9 MB)

Committee meeting

Committee meeting: 2

Committee meeting: 2

Final scope (PDF 196 KB)

Final stakeholder list (PDF 166 KB)

Equality impact assessment (Scoping) (PDF 126 KB)

Note

Note

Draft matrix post referral (PDF 166 KB)